TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

More documents

Recommendations

Info

2008;22:601-17. 1.403 Donders GG. Management of genital infections in pregnant women. Curr Opin Infect Dis 2006;19: 55-61. 1.404 Geisler WM. Approaches to the management of uncomplicated genital Chlamydia trachomatis infections. Expert Rev Anti Infect Ther 2004;2:771-85. 1.405 Peipert JF. Genital chlamydial infections. N Engl J Med 2003;349:2424-30. 1.406 Bébéar C et al. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009;15:4-10. 1.407 Kalwij S et al. Screening and treatment of Chlamydia trachomatis infections. Br Med J 2010;340: c1915. 1.408 Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44(suppl. 3):S77-83. 1.409 Lewis DA. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect 2003; 79:68-71. 1.410 Newman LM et al. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007;44(suppl. 3):S84-101. 1.411 Bignell C. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2009;20:453-7. 1.412 Schachter J et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-8. 1.413 Cook RL et al. Systematic review: non invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25. 1.414 Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005; 19:853-61. 1.415 Hart G. Donovanosis. Clin Infect Dis 1997;25:24-32. 1.416 Prichens J. Donovanosis (granuloma inguinale). Sex Transm Infect 2006;82(suppl. 4):iv21-2. 1.417 McLean CA et al. Treatment of lymphogranuloma venereum. Clin Infect Dis 2007;44(suppl. 3): S147-52. 1.418 White JA. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009;22:57-66. 1.419 Richardson D et al. Lymphogranuloma venereum: an emerging cause of proctitis in men who have sex with men. Int J STD AIDS 2007;18:11-16. 1.420 Van der Bij AK et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case control study. Clin Infect Dis 2006;42:186-94. 1.421 de Vries HJ et al. Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. Clin Infect Dis 2009;48:e53-6. 1.422 Katz KA et al. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis 2008;21:83-91. 1.423 French P et al. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 2009;20:300-9. 1.424 Gayet-Ageron A et al. Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples. Sex Transm Infect 2009;85:264-9. 1.425 Hook EW et al. Syphilis control. A continuing challenge. N Engl J Med 2004;351:122-4. 1.426 Stoner BP. Current controversies in the treatment of adult syphilis. Clin Infect Dis 2007;44(suppl. 3): S130-46. 1.427 French P. Syphilis. Br Med J 2007;334:143-7. 1.428 Baughn RE et al. Secondary syphilitic lesions. Clin Microbiol Rev 2005;18:205-16. 1.429 Ghanem et al. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006;42:e45-9. 1.430 Wong T et al. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med 2008;121:903-8. 1.431 Bai ZG et al. Azithromycin vs benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS 2008;19:217-21. 1.432 Centers for Disease Control nad Prevention (CDC). Symptomatic early neurosyphilis among HIV-positive men who have sex with men – four cities, United States, January 2002-June 2004. Morb Mortal Wkly Rep 2007;56:625-8. 1.433 Lynn WA et al. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004;4:456-66. 1.434 Marra CM et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004;189:369-76. 1.435 Marra CM et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004;38:1001-6. 1.436 Gaydos C et al. Mycoplasma genitalium compared to Chlamydia, gonorrhoea and Trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect 2009;85:438-40. 1.437 Shahmanesh M et al. 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS 2009;20:458-64. 1.438 Bradshaw CS et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006;193:336-45. 1.439 Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44(suppl. 3):S77-83. 1.440 Mena LA et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009;48:1649-54. 1.441 Jensen JS. Single-dose azithromycin treatment for Mycoplasma genitalium-positive urethritis: best but not good enough. Clin Infect Dis 2009;48:1655-6. 1.442 Yokoi S et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal uerthritis. Clin Infect Dis 2007;45:866-71. 1.443 Schwebke JR et al. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003;188:465-8. 1.444 Centers for Disease Control and Prevention (CDC). Update to CDC‘s sexually transmitted diseases guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Morb Mortal Wkly Rep 2007;56:332-6. 1.445 Ghanem KG et al. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005;19:351-65.
1.446 Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases. Treatment guidelines 2006. Morb Mortal Wkly Rep 2006;55(RR-11):1-94. 1.447 Hollier LM et al. Treatment of sexually transmitted infections in women. Infect Dis Clin North Am 2008;22:665-91. 1.448 Lusk MJ et al. Cervicitis: a review. Curr Opin Infect Dis 2008;21:49–55. 1.449 Ross J et al. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2007;18:662-6. 1.450 Walker CK et al. Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44(suppl. 3):S111-22. 1.451 Faro C et al. Postoperative pelvic infections. Infect Dis Clin North Am 2008;22:653-663. 1.452 Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis 2010;23: 83-7. 1.453 Lareau SM et al. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am 2008;22:693-708. 1.454 Haggerty CL et al. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis 2007;44:953-60. 1.455 Short VL et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009;48:41-7. 1.456 Haggerty C et al. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 2008;21:65-9. 1.457 Eckert LO. Acute vulvovaginitis. N Engl J Med 2006;355:1244-52. 1.458 Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis 2009;22:82–6. 1.459 Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am 2008;22:637- 52. 1.460 Fethers KA et al. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 2008;47:1426-35. 1.461 Verstraelen H et al. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect Ther 2009;7:1109-24. 1.462 Okun N et al. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005;105:857-68. 1.463 Sobel JD. What‘s new in bacterial vaginosis and trichomoniasis? Infect Dis Clin North Am 2005;19: 387-406. 1.464 Spence D et al. Vaginal discharge. Br Med J 2007;335:1147-51. 1.465 Marrazzo JM. Evolving issues in understanding and treating bacterial vaginosis. Expert Rev Anti Infect Ther 2004;2:913-22. 1.466 Bradshaw CS et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86. 1.467 De Backer E et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis 2006;6:51. 1.468 Ugwumadu A et al. Effect of early clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983-8. 1.469 Yudin MH et al. Screening and management of bacterial vaginosis in pregnancy. J Obstet Gynaecol Can 2008;30:702-8. 1.470 Schwebke JR et al. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007;44:213-9. 1.471 Centers for Disease Control and Prevention (CDC). Update to CDC‘s sexually transmitted diseases guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Morb Mortal Wkly Rep 2007;56:332-6. 1.472 Ghanem KG et al. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005;19:351-65. 1.473 Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases. Treatment guidelines 2006. Morb Mortal Wkly Rep 2006;55(RR-11):1-94. 1.474 Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia 2008;40: 76-80. 1.475 Edwards SK. European guideline for the management of balanoposthitis. Int J STD AIDS 2001;12 (suppl. 3):68-72. 1.476 Lisboa C et al. Infectious balanoposthitis: management, clinical and laboratory features. Int J Dermatol 2009;48:121-4. 1.477 Horner PJ. European guideline for the management of epididymo-orchitis and syndromic management of acute scrotal swelling. Int J STD AIDS 2001;12(suppl. 3):88-93. 1.478 Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355: 1690-8. 1.479 McNaughton Collins M et al. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000;133:367-81. 1.480 Alexander RB et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann Intern Med 2004;141:581-9. 1.481 Lipsky BA et al. Treatment of bacterial prostatitis. Clin Infect Dis 2010;50:1641-52. 1.482 Domingue GJ et al. Prostatitis. Clin Microbiol Rev 1998;11:604-13. 1.483 Wagenlehner FM et al. Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther 2003;1: 275-82. 1.484 Wagenlehner FM et al. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect 2006;12(suppl. 3):67-80. 1.485 Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355: 1690-8. 1.486 Tosti R et al. Empiric antibiotics for acute infections of the hand. J Hand Surg 2010;35:125-8. 1.487 Clark DC. Common acute hand infections. Am Fam Physician 2003;68:2167-76. 1.488 Spann M et al. Hand infections: basic principles and management. Surg Infect 2004;5:210-20. 1.489 Rigopulos D et al. Acute and chronic paronychia. Am Fam Physician 2008;77:339-46. 1.490 Baddour LM et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015- 31. 1.491 Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350: 1422-9.
Page 1 and 2: TABLE 39A LIST OF PUBLICATIONS REFE
Page 3 and 4: 1.89 Laupland KB. Vascular and para
Page 5 and 6: of NICE guidance. Br Med J 2008;337
Page 7 and 8: tions à Clostridium difficile dans
Page 9: sis of placebo-controlled trials. C
Page 13 and 14: 1.532 Olaison L et al. Enterococcal
Page 15 and 16: 1.615 Muder RR et al. Isolation of
Page 17 and 18: 2005;352:865-74. 1.699 Brown-Elliot
Page 19 and 20: 2009;123:1108-15. 1.782 Ellis MW. A
Page 21 and 22: 1.873 Korting HC et al. Current top
Page 23 and 24: 1.970 Thomas RJ et al. Current mana
Page 25 and 26: of severe respiratory failure. Clin
Page 27 and 28: 1.1166 Aldape MJ et al. Clostridium
Page 29 and 30: 2A.36 Wormser GP. Early Lyme diseas
Page 31 and 32: test methodology. Eur J Clin Microb
Page 33 and 34: 2B.39 Cookson BD et al. Guidelines
Page 35 and 36: 2009;15(suppl. 3):7-11. 2B.115 Jaco
Page 37 and 38: 82. 4A.87 de Smet AM et al. Deconta
Page 39 and 40: after acute pyelonephritis: a multi
Page 41 and 42: for intensive care patients with no
Page 43 and 44: among hospitalized patients. Clin I
Page 45 and 46: Ther 2006;4:947-52. 5D.1 Demirovic
Page 47 and 48: 7.38 Meersseman W et al. Invasive a
Page 49 and 50: 7.121 Walsh TJ et al. All catheter
Page 51 and 52: nail onychomycosis. J Eur Acad Derm
Page 53 and 54: 2006. Clin Infect Dis 2006;43:1580-
Page 55 and 56: 9A.5 Andes D. Pharmacokinetics and
Page 57 and 58: factor and other newly approved bio
Page 59 and 60: cument E.DEF 8.1). Report of the Su
Page 61 and 62:
Br J Dermatol 2004;151:1096-100. 11
Page 63 and 64:
new prediction equation. Ann Intern
Page 65 and 66:
14A.93 Sundar S et al. New treatmen
Page 67 and 68:
eview. Obstet Gynecol 2005;105:857-
Page 69 and 70:
2003;1:471-82. 14A.278 Walker MD et
Page 71 and 72:
14B.4 Checkley AM et al. Eosinophil
Page 73 and 74:
18.12 Panel on Antiretroviral Thera
Page 75 and 76:
18.91 Lesho E. Evidence base for us
Page 77 and 78:
tients. J Antimicrob Chemother 2009
Page 79 and 80:
duct characteristics. Available at:
Page 81 and 82:
_Product_Information/human/000338/W
Page 83 and 84:
114:23-33. 21.80 Jabs DA et al. Fom
Page 85 and 86:
North Am 2006;20:155-74. 21.176 Nas
Page 87 and 88:
1995;14:827-32. 21.264 Scott LL. Pe
Page 89 and 90:
21.358 Calabrese LH et al. Viral Ar
Page 91 and 92:
24. 21.452 Jeha LE et al. Long term
Page 93 and 94:
induced functional androgen deficie
Page 95 and 96:
25A.27 Conseil Supérieur de la San
Page 97 and 98:
product characteristics. Available
Page 99 and 100:
mortality after kidney transplantat
Page 101 and 102:
33A.1 Kearney BP et al. The penetra
Page 103 and 104:
Clin Plast Surg Clinics in Plastic
Page 105 and 106:
Mycopathologia Mycopathologia Mycos
show all

TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?